Related references
Note: Only part of the references are listed.The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis
Antonietta Gentile et al.
NEUROBIOLOGY OF DISEASE (2015)
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission
Silvia Rossi et al.
NEUROPHARMACOLOGY (2015)
The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders
Ekaterina Dobryakova et al.
FRONTIERS IN NEUROLOGY (2015)
Cannabinoid Receptor-Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
Tricia H. Smith et al.
MOLECULAR PHARMACOLOGY (2015)
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
Silvia Rossi et al.
MOLECULAR NEURODEGENERATION (2014)
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis
Francesco Mori et al.
NEUROMOLECULAR MEDICINE (2014)
Cellular and Behavioral Outcomes of Dorsal Striatonigral Neuron Ablation: New Insights into Striatal Functions
Delphine Revy et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Altered cognitive-emotional behavior in early experimental autoimmune encephalitis - Cytokine and hormonal correlates
Shaona Acharjee et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice
Maria Jesus Luque-Rojas et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Interleukin-1β Alters Glutamate Transmission at Purkinje Cell Synapses in a Mouse Model of Multiple Sclerosis
Georgia Mandolesi et al.
JOURNAL OF NEUROSCIENCE (2013)
Behavioural and Anatomical Characterization of Mutant Mice With Targeted Deletion of D1 Dopamine Receptor-Expressing Cells: Response to Acute Morphine
Daniela Babovic et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2013)
INTERLEUKIN-1β ALTERS THE SENSITIVITY OF CANNABINOID CB1 RECEPTORS CONTROLLING GLUTAMATE TRANSMISSION IN THE STRIATUM
V. de Chiara et al.
NEUROSCIENCE (2013)
Correction: Regulation of Cyclooxygenase-2 Expression by Heat: A Novel Aspect of Heat Shock Factor 1 Function in Human Cells
Antonio Rossi et al.
PLoS One (2013)
Behavioral Characterization of A53T Mice Reveals Early and Late Stage Deficits Related to Parkinson's Disease
Katrina L. Paumier et al.
PLOS ONE (2013)
TNF-α-mediated anxiety in a mouse model of multiple sclerosis
Nabila Haji et al.
EXPERIMENTAL NEUROLOGY (2012)
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System
Silvia Rossi et al.
JOURNAL OF NEUROSCIENCE (2012)
Endocannabinoids in Amygdala and Nucleus Accumbens Mediate Social Play Reward in Adolescent Rats
Viviana Trezza et al.
JOURNAL OF NEUROSCIENCE (2012)
Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice
Jaqueline Nascimento Picada et al.
ACTA PHARMACOLOGICA SINICA (2011)
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis
Silvia Rossi et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis
Silvia Rossi et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis
Gabriele Musumeci et al.
NEUROBIOLOGY OF DISEASE (2011)
Brain-Derived Neurotrophic Factor Controls Cannabinoid CB1 Receptor Function in the Striatum
Valentina De Chiara et al.
JOURNAL OF NEUROSCIENCE (2010)
Role of Aberrant Striatal Dopamine D1 Receptor/cAMP/Protein Kinase A/DARPP32 Signaling in the Paradoxical Calming Effect of Amphetamine
Francesco Napolitano et al.
JOURNAL OF NEUROSCIENCE (2010)
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
Eric J. Topol et al.
LANCET (2010)
The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain
E. Ramil et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study
Salvatore Lo Fermo et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Depression-like phenotype following chronic CB1 receptor antagonism
Chad E. Beyer et al.
NEUROBIOLOGY OF DISEASE (2010)
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum
Valentina De Chiara et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function
Ahmad R. Hariri et al.
BIOLOGICAL PSYCHIATRY (2009)
Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission
W. Jacob et al.
GENES BRAIN AND BEHAVIOR (2009)
Impairments in Endocannabinoid Signaling and Depressive Illness
Matthew N. Hill et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis
Diego Centonze et al.
JOURNAL OF NEUROSCIENCE (2009)
Deep gray matter atrophy in multiple sclerosis: A tensor based morphometry
Guozhi Tao et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
TRPV1 channels facilitate glutamate transmission in the striatum
Alessandra Musella et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Adaptations of Striatal Endocannabinoid System During Stress
Silvia Rossi et al.
MOLECULAR NEUROBIOLOGY (2009)
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated
R. A. Marrie et al.
MULTIPLE SCLEROSIS (2009)
Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels
Vincenzo Micale et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment
Ida S. Haussleiter et al.
Therapeutic Advances in Neurological Disorders (2009)
The endocannabinoid system and multiple sclerosis
David Baker et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism
Tanya L. Daigle et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum
Silvia Rossi et al.
JOURNAL OF NEUROSCIENCE (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Developmental exposure to trichloroethylene promotes CD4+ T cell differentiation and hyperactivity in association with oxidative stress and neurobehavioral deficits in MRL+/+ mice
Sarah J. Blossom et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Bimodal effect of amphetamine on motor behaviors in C57BL/6 mice
Jonathan W. Yates et al.
NEUROSCIENCE LETTERS (2007)
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis
Diego Centonze et al.
BRAIN (2007)
Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons
Diego Centonze et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors
Diego Centonze et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling
Sachin Patel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission
Maria R. Domenici et al.
JOURNAL OF NEUROSCIENCE (2006)
Cytokines in multiple sclerosis: from bench to bedside
J Imitola et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
G Pryce et al.
BRAIN (2003)
The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators
Y Pollak et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
Expression of tumor necrosis factor-α and interferon-γ mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis
KG Kahl et al.
PSYCHONEUROENDOCRINOLOGY (2002)
Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter
C Spielewoy et al.
PSYCHOPHARMACOLOGY (2001)
The relationship of depression and stressors to immunological assays: A meta-analytic review
EP Zorrilla et al.
BRAIN BEHAVIOR AND IMMUNITY (2001)
Behavioral aspects of experimental autoimmune encephalomyelitis
Y Pollak et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)